Skip To Main Content
Robison LL on Muck Rack

Robison LL

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Robison LL’s profile

Articles by Robison LL

Improving quality and quantity of life for childhood cancer survivors globally in the twenty-first century

|
By Ehrhardt MJ, Krull KR, Robison LL, Hudson MM
| nlm.nih.gov
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
Open in Who Shared View Duplicates (615) Issue with article?

Cardiac Substructure Radiation Dose and Risk of Late Cardiac Disease in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study - PubMed

|
By Smith SA, Robison LL, Bates JE, Mulrooney DA
| ncbi.nlm.nih.gov
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
Open in Who Shared View Duplicates (621) Issue with article?

Acute lymphoblastic leukemia: a comprehensive review and 2017 update

|
By John BM, Jabbour EJ, O'Brien S, Robison LL
| Nature Verified
CD22 is a B-lineage differentiation antigen expressed in B-cell ALL in 50–100% of adults and 90% of children.78, 79, 80 Upon binding of an antibody, CD22 is rapidly internalized, thus making it an attractive target for delivering immunotoxin to leukemic cells.81 Epratuzumab is an unconjugated monoclonal antibody targeting CD22 that has been studied in pediatric and adult relapsed/refractory ALL. Epratuzumab was evaluated in 15 pediatric patients as part of a salvage therapy regimen.
Open in Who Shared Issue with article?
Show More